Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

By A. Zaki, S. van Boheemen, T. Bestebroer, A. Osterhaus, R. Fouchier. New England Journal of Medicine, 2012

5,406 citations recorded by the source corpus.

Subfields: Animal Science and Zoology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/75430b151f5307a2a38513a28c2ddea4489ee2e2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Animal Science and Zoology

In Infectious Diseases

Citations in the corpus

SARS and MERS: recent insights into emerging coronaviruses (2016, positive): “This approach yielded an inhibitor of Tylonycteris bat coronavirus HKU4 (HKU4-CoV), which is closely related to MERS-CoV 11 .”
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection (2020, methodology): “After SARS-CoV [5–8] and Middle East respiratory syndrome coronavirus (MERS-CoV) [9, 10], SARS-CoV-2 is the third of such viruses to threat public health around the world during the past two decades [11, 12].”
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry (2019, background): “and MERS coronavirus (MERS-CoV), cause lethal infections in humans (13-16).”
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology (2017, background): “This high replication could lead to enhanced cytopathic effects and production of higher levels of proinflammatory cytokines and chemokines by infected epithelial cells [99, 68, 12].”
A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples (2014, background): “Ongoing discovery of novel pathogens, such as Bas-Congo rhabdovirus (Grard et al. 2012) and MERS (Middle East Respiratory Syndrome) coronavirus (Zaki et al. 2012), also un-derscores the need for rapid, broad-spectrum diagnostic assays that are able to recognize these emerging agents.”
The SARS-CoV-2 outbreak: What we know (2020, background): “To date, there have six human coronaviruses (HCoVs) been identified, including the alpha-CoVs HCoVs-NL63 and HCoVs-229E and the beta-CoVs HCoVs-OC43, HCoVs-HKU1, severe acute respiratory syndrome-CoV (SARS-CoV)([3]), and Middle East respiratory syndrome-CoV (MERS-CoV)([4]).”
Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group (2013, background): “During the summer of 2012, in Jeddah, Saudi Arabia, a hitherto unknown coronavirus (CoV) was isolated from the sputum of a patient with acute pneumonia and renal failure (1, 2).”
SARS-CoV-2 Spike protein variant D614G increases infectivity and retains sensitivity to antibodies that target the receptor binding domain (2020, positive): “Previous structural studies of SARS-CoV and MERS-CoV S proteins identified similar conformations, with only MERS-CoV S protein exhibiting an all open state like that reported here (Gui et al., 2017; Pallesen et al., 2017; Walls et al., 2019; Yuan et al., 2017).”
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. (2020, background): “quartile range) interval from symptom onset to hospital admission is 7 (3-9) days.”
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses (2016, background): “MERS-CoV was first isolated from the lungs of a 60-year-old patient who had died from a severe respiratory illness in Jeddah, Saudi Arabia, 2012 [39] .”